CLINICAL_TRIALS
trial_result
· 2020-03-03
Clinical Trial Update: BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease [Phase 3]
Summary
Phase 3 trial evaluating benznidazole for chronic Chagas disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Population Health Research Institute | Conditions: Chagas Disease, Trypanosomiasis | Phase 3 | Status: COMPLETED